
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About
agilon health Inc (AGL)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/10/2025: AGL (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $4.25
1 Year Target Price $4.25
4 | Strong Buy |
0 | Buy |
14 | Hold |
2 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -13.9% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 964.58M USD | Price to earnings Ratio - | 1Y Target Price 4.25 |
Price to earnings Ratio - | 1Y Target Price 4.25 | ||
Volume (30-day avg) 20 | Beta 0.14 | 52 Weeks Range 1.50 - 7.73 | Updated Date 07/11/2025 |
52 Weeks Range 1.50 - 7.73 | Updated Date 07/11/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.62 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -4.04% | Operating Margin (TTM) -1.41% |
Management Effectiveness
Return on Assets (TTM) -8.85% | Return on Equity (TTM) -42.97% |
Valuation
Trailing PE - | Forward PE 178.57 | Enterprise Value 622884573 | Price to Sales(TTM) 0.16 |
Enterprise Value 622884573 | Price to Sales(TTM) 0.16 | ||
Enterprise Value to Revenue 0.1 | Enterprise Value to EBITDA -104.52 | Shares Outstanding 413952000 | Shares Floating 307417149 |
Shares Outstanding 413952000 | Shares Floating 307417149 | ||
Percent Insiders 2.1 | Percent Institutions 97.74 |
Upturn AI SWOT
agilon health Inc
Company Overview
History and Background
Agilon Health, Inc. was founded in 2016 and went public in April 2021. It focuses on partnering with physician groups to help them transition to value-based care models.
Core Business Areas
- Partnering with Physician Groups: Agilon provides a full-risk platform and partnership model that enables physician groups to improve the quality of care, lower the total cost of care, and enhance the patient experience.
- Value-Based Care Enablement: Offers data and analytics, population health management, and other services to support physician groups in value-based care arrangements.
Leadership and Structure
The leadership team includes the CEO and other senior executives. The company has a corporate structure with departments focused on partnerships, operations, technology, and finance.
Top Products and Market Share
Key Offerings
- AgilonONE Platform: A platform that enables physician groups to manage patient populations, analyze data, and coordinate care. Competitors include Privia Health (PRVA) and OptumCare, though these are complete solutions while Agilon sells its platform as software. Agilon has 2,200 primary care physicians across 17 regions. Revenue contribution not publicly broken out for this specific platform.
- Risk-Bearing Entity: Agilon assumes full financial risk for patient populations under value-based care contracts. Revenue is derived from capitation payments and shared savings arrangements. Competitors include Accolade (ACCD) and other companies offering value-based care solutions. Revenue derived not specifically broken out but constitutes a significant portion of the company's overall revenue.
Market Dynamics
Industry Overview
The healthcare industry is shifting towards value-based care models, driven by the need to improve outcomes and control costs. This involves moving away from fee-for-service and towards paying providers based on the quality and efficiency of care.
Positioning
Agilon Health is positioned as a key enabler of value-based care, offering a comprehensive platform and partnership model for physician groups. Its competitive advantage lies in its full-risk model, data analytics capabilities, and strong relationships with physician groups.
Total Addressable Market (TAM)
The total addressable market for value-based care is estimated to be in the hundreds of billions of dollars. Agilon Health is positioned to capture a significant portion of this market by partnering with physician groups to drive adoption of value-based care models.
Upturn SWOT Analysis
Strengths
- Comprehensive value-based care platform
- Strong partnerships with physician groups
- Data analytics capabilities
- Full-risk model
Weaknesses
- Reliance on physician group partnerships
- Concentration of revenue in certain markets
- Dependence on government regulations and healthcare policies
Opportunities
- Expansion into new geographic markets
- Growth in value-based care adoption
- Development of new products and services
- Strategic acquisitions and partnerships
Threats
- Increased competition
- Changes in government regulations and healthcare policies
- Economic downturn
- Cybersecurity threats
Competitors and Market Share
Key Competitors
- Alignment Healthcare (ALHC)
- Privia Health (PRVA)
- Oak Street Health (OSH)
Competitive Landscape
Agilon Health faces competition from other value-based care companies, health insurers, and physician practice management companies. Its competitive advantage lies in its comprehensive platform, strong partnerships with physician groups, and full-risk model.
Growth Trajectory and Initiatives
Historical Growth: Agilon has experienced strong revenue growth in recent years, driven by the increasing adoption of value-based care and its successful partnerships with physician groups.
Future Projections: Analysts project continued revenue growth for Agilon Health, driven by further expansion into new markets and the increasing adoption of value-based care. Profitability is expected to improve as the company achieves economies of scale.
Recent Initiatives: Recent initiatives include expanding into new geographic markets, launching new products and services, and strengthening partnerships with physician groups.
Summary
Agilon Health shows moderate strength as it facilitates the shift towards value-based care through partnerships. Revenue growth is fueled by value-based initiatives, but profitability needs attention. Agilon must manage competition and adapt to policy changes to ensure continued expansion and maintain its advantageous position in the market. It needs to expand margins and continue to grow its network of physicians to ensure sustained success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Investor Relations
- Analyst Reports
- Press Releases
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Actual results may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About agilon health Inc
Exchange NYSE | Headquaters Westerville, OH, United States | ||
IPO Launch date 2021-04-15 | President, CEO & Director Mr. Steven Jackson Sell | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1076 | Website https://www.agilonhealth.com |
Full time employees 1076 | Website https://www.agilonhealth.com |
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.